Biotechnology companies apply biological science to develop products, services and technologies that address challenges in healthcare, agriculture, industry and environmental sustainability.
This category includes companies working on:
Browse 463 UK biotechnology companies below.
Mitochondrial DNA liquid biopsy tests for cancer and disease detection
MDNA Life Sciences is a biotechnology company developing proprietary diagnostic tests based on mitochondrial DNA biomarkers. Its technology detects specific mitochondrial DNA…
High-capacity viral vector manufacturing platform for gene therapy
Icosphere Biosciences is a biotechnology company developing manufacturing technology for high-capacity gene therapy vectors. Its platform enables scalable, high-yield,…
Raman spectroscopy blood test for early cancer detection
CanSense is a Welsh biotechnology company developing a non-invasive blood test for the early detection of bowel and other cancers. The platform combines Raman laser spectroscopy…
End-to-end production systems for cultivated meat
Cellcraft is a biotechnology company developing integrated systems for cultivated meat production. The company supplies the hardware, software, and biological inputs required to…
AI-ready cellular perturbation datasets for drug discovery
CellCodex is a Cambridge-based company generating large-scale cellular perturbation datasets for the training of foundation AI models in biology. The company combines CRISPR…
Personalised cancer treatment selection using in vivo drug screening
Vivan Therapeutics is a London-based biotech developing a personalised cancer therapeutics platform. The company's Personal Discovery Process sequences a patient's tumour genome,…
AI-powered RNAi drug discovery company developing hepatic medicines
Tangram Therapeutics is a biotechnology company combining artificial intelligence and RNA interference to discover and develop novel medicines. Its proprietary chemistry platform…
Bicistronic AAV gene therapies for retinal disease
Ikarovec is a near-clinical-stage gene therapy company developing bicistronic AAV-based therapeutics for vision-threatening retinal diseases. Its proprietary platform combines two…
Phase III-ready antimicrobial advancing post-surgical infection prevention
AMR Bio is a clinical-phase biotechnology company advancing XF-73, a Phase III-ready topical antimicrobial using an ultra-rapid antibacterial mechanism to prevent post-surgical…
Targeted oncology combination therapies in biomarker-defined cancer populations
Mosaic Therapeutics is a Cambridge biotech developing targeted combination therapies for cancer. Its proprietary platform integrates genome-scale CRISPR screening, high-throughput…
AAV gene therapy targeting the seizure focus in refractory epilepsy
EpilepsyGTx is a biotechnology company developing gene therapies for focal refractory epilepsy, a condition in which seizures arise from a specific brain region and do not respond…
Anti-inflammatory drugs for neurodegenerative disease
Sitala Bio is a Cambridge-based biotech developing small molecule drugs that target chronic neuroinflammation in conditions such as Parkinson's and Alzheimer's disease. The…